Results for tag: "Metabolic Disease"

The Metabolic Disease market within the context of Endocrinology is focused on the diagnosis, treatment, and management of metabolic diseases. These diseases are caused by a disruption in the body's metabolism, which is the process of converting food into energy. Metabolic diseases can be caused by genetic mutations, lifestyle choices, or environmental factors. Common metabolic diseases include diabetes, obesity, and thyroid disorders. Treatment for metabolic diseases often includes lifestyle changes, such as diet and exercise, as well as medications and supplements. The Metabolic Disease market is a growing field, with new treatments and technologies being developed to improve patient outcomes. Companies in this market include Novo Nordisk, Sanofi, Merck, and Eli Lilly. These companies are focused on developing treatments for metabolic diseases, as well as providing diagnostic and monitoring services. Show Less Read more